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Adeno-associated viruses (AAV) are replication-defective mem-
bers of the parvovirus family (Cotmore and Tattersall, 2007) that have
emerged as one of the leading platforms for the development of viral
vectors (Buning et al., 2008). AAV's DNA genome is packaged into a
non-enveloped capsid composed of the three structural proteins VP1,
VP2 and VP3 (Bleker et al., 2005). These proteins are expressed
from the same open reading frame and share most of their amino
acid sequence (Bleker et al., 2005). VP1 and VP2 differ from VP3 by an
N-terminal extension of 65 amino acids (Bleker et al., 2005; Xie et al.,
2003) whereas VP1 contains further 137 unique amino acids
(Warrington et al., 2004; Xie et al., 2003). Although VP1 is dispensable
for assembly and packaging of viral DNA, it is required for viralinfectivity indicating the presence of functional domains within the
unique VP1 region (Bleker et al., 2005; Girod et al., 2002; Kronenberg
et al., 2005). Besides nuclear localization sequences found in VP1 and
VP2 (Grieger et al., 2006; Sonntag et al., 2006), Zadori et al. (2001)
identiﬁed a secreted phospholipase A2 (sPLA2) homology domain
that is unique to VP1 and highly conserved among the parvovirus
family. This domain is buried within the capsid interior but becomes
externalized through pores found at the 5-fold symmetry axis during
passage of AAV through the endosomal compartment (Bleker et al.,
2005; Sonntag et al., 2006).
Non-parvoviral sPLA2s are known as key enzymes in lipid
membrane metabolism, signal transduction pathways, inﬂammation,
acute hypersensitivity, and degenerative diseases (Balsinde et al.,
1999; Dennis, 1997; Kramer and Sharp, 1997). They hydrolyze
phospholipid substrates at the 2-acyl-ester (sn-2) position to release
lysophospholipids and free fatty acids (Zadori et al., 2001). Parvoviral
sPLA2 shows the same enzymatic activity when expressed as a
recombinant protein (Canaan et al., 2004). The sequence similarity of
non-parvoviral and parvoviral sPLA2s is largely conﬁned to the
catalytic HDXXY domain and to the calcium binding GXG motif
(Canaan et al., 2004). Mutations in either of these regions reduce the
enzymatic activity and viral infectivity by several orders of magnitude,
hinting at a pivotal function of the sPLA2 domain in the parvoviral life
Fig. 1. Quantiﬁcation of cell entry efﬁciency. HeLa cells were incubated with 104
genomic particles per cell (GOI) of rAAV2-wt (wt) or the sPLA2mutant 76HD/AN (76HD/
AN), respectively, for 30 min on ice followed by 1 h at 37 °C. Unbound and cell
membrane bound vector particles were removed, total DNA was isolated and assayed
for vector genomes by qPCR using GAPDH as a reference gene. Vector genomes encoded
for the reporter gene GFP in a self-complementary vector genome conformation.
Background levels obtained for untreated cells were subtracted. Values are shown as
means±SD (n=3).
78 S. Stahnke et al. / Virology 409 (2011) 77–83cycle (Girod et al., 2002; Li et al., 2001; Zadori et al., 2001). Recently,
Farr et al. reported that polyethyleneimine (PEI)-induced endosomal
rupture or co-infection with endosomolytically active adenoviruses
partially rescued the infectivity of a catalytic center sPLA2 mutant
(H42R) of the autonomously replicating parvovirus Minute Virus of
Mice (MVM). They concluded that the sPLA2 activity plays a role in
breaching the endosomal membrane to facilitate endosomal escape of
incoming MVM particles (Farr et al., 2005).
Although AAV—as a replication-defective member of the parvovi-
rus family—differs substantially in its virus–cell interaction from the
autonomously replicating parvoviruses (Cotmore and Tattersall,
2007), it has been postulated that AAV's sPLA2 homology domain
serves the same function. In order to explore this hypothesis, we
compared recombinant AAV serotype 2 vectors with wild-type sPLA2
activity to our previously described sPLA2 catalytic center mutant
76HD/AN (Girod et al., 2002). The sPLA2 defect in 76HD/AN, which had
no impact on cellular uptake, could be partially rescued by co-
infection with endosomolytically active, but not with inactiveFig. 2. Kinetic of rAAV2-wt- and 76HD/AN-mediated transgene expression. A) HeLa cells w
stained with the monoclonal anti-capsid antibody A20 (and RRX-conjugated secondary ant
(and Cy5-conjugated secondary antibody). B) HeLa cells were incubated with rAAV2-wt (G
Both vectors encode for GFP in the self-complementary vector genome conformation. Cells w
GFP expression by ﬂow cytometry. Values obtained for untreated cells were subtracted. Resu
30 min, 1 h, 2 h, 3 h and 4 h p.t.adenoviral variants, leading to the conclusion that sPLA2 mutants
are trapped in endosomes. These data provide the ﬁrst experimental
evidence for a function of sPLA2 in endosomal escape of incoming
adeno-associated viruses revealing that replication-defective, i.e.
helper-virus-dependent, and autonomously replicating parvoviruses
use the same strategy to escape lysosomal degradation.Results and discussion
In 2002, we reported on the cloning of four sPLA2 mutants of AAV
serotype 2 (AAV2), where we had either replaced the catalytic center
histidine (75H) and aspartate (76D) residues by alanine (A) and
asparagine (N) (76HD/AN) or introduced deletions into the calcium
binding loop (ΔXX, ΔBH and ΔBH+L) (Girod et al., 2002). Consistent
with a function of the sPLA2 homology domain in endosomal escape
of incoming AAV particles, the mutants showed a delayed onset and
low expression level of the Rep gene products, but no defects in capsid
assembly, viral genome packaging, cell surface binding, cell entry or
intracellular trafﬁcking. However, experimental evidence for an
involvement of sPLA2 in endosomal escape is still lacking. The
purpose of this study was therefore to examine whether the poor
infectivity of sPLA2 mutants of AAV2 could be rescued by breaking
endosomal integrity. Out of the four mutants, we chose 76HD/AN
(Girod et al., 2002) as the closest equivalent to theMVMmutant H42R
used by Farr et al. (2005). To minimize bias due to the helper virus
dependency of AAV for viral gene expression, we generated 76HD/AN
as a recombinant vector encoding for the enhanced green ﬂuorescent
protein (GFP) in a self-complementary vector genome conformation.
For comparison, the same vector genome was packaged into AAV2
capsids with a wild-type (wt) sPLA2 activity (rAAV2-wt). In line with
our previous report (Girod et al., 2002), rAAV2-wt and 76HD/AN were
indistinguishable in terms of packaging efﬁciency (data not shown)
and their ability to enter HeLa cells (Fig. 1) and to accumulate in the
perinuclear area (Fig. 2A), but differed signiﬁcantly in the amount of
vector genomes available in the nucleus for gene expression as
indicated by the mutant's delayed onset in transgene expression and
the low transduction efﬁciency (Fig. 2B). The latter becomes even
more obvious when a lower genomic particle per cell ratio (GOI) is
used: for example at a GOI of 1000 the transduction efﬁciency of 76HD/ere infected with rAAV2-wt (wt) or 76HD/AN and ﬁxed at 2 h p.t. Intact capsids were
ibody), and nuclear lamina was visualized by a polycloncal anti-Lamin B IgG antibody
OI of 104, diamond) or 76HD/AN (GOI of 104 (square) and 105 (triangle)), respectively.
ere harvested at 0 min, 30 min, 1 h, 2 h, 3 h, 4 h, 11 h, 24 h and 48 h p.t., and analyzed for
lts are the mean±SD (n=3). C) Higher resolution of graph B) for the time points 0 min,
Fig. 4. Transduction efﬁciency of rAAV2-wt and 76HD/AN. HeLa cells were incubated
with a GOI of 10 of rAAV2-wt (wt) and 2×105 of 76HD/AN, respectively, for 24 h. Cells
were harvested by trypsin treatment and the percentage of transgene (GFP) expressing
cells was determined by ﬂow cytometry. Background levels obtained for untreated cells
were subtracted. Results are shown as means±SD (n=3). Diamonds indicate the GOIs
used for rAAV2-wt (wt) and 76HD/AN, respectively.
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to rAAV2-wt reaching 96.1±1.7% (n=4).
While the sPLA2 defect could be complemented in trans by
addition of wild-type sPLA2 activity in case of MVM (Farr et al., 2005)
this was not the case in our previous study nor in the study of Zadori
et al. on porcine parvovirus (Girod et al., 2002; Zadori et al., 2001).
Since, in these studies (Girod et al., 2002; Zadori et al., 2001) only one
mutant-to-wild-type ratio was tested, we decided to re-evaluate the
question as to whether the sPLA2 activity is required for 76HD/AN
transduction in cis or trans. To this end, HeLa cells were co-infected
with 76HD/AN encoding for GFP in a self-complementary genome
conformation and wild-type AAV2 virions. Assuming that the
potential helper effect of AAV2's wild-type sPLA2 activity has to
overcome the inhibitory effect of receptor competition, we assayed a
wide range of 76HD/AN-to-wild-type AAV2 ratios (between 1:0.01
and 1:100). As indicated by the increase in the number of GFP-
expressing cells, co-infection with wild-type AAV2 can rescue 76HD/
AN's defect by trans complementation (Fig. 3), in line with the results
for MVM. However, the window of trans complementation activity is
narrow, since a signiﬁcant increase in transduction efﬁciencywas only
observed at a mutant-to-wild-type ratio of 1:1, whereas ratios of
1:100, 1:10 or 1:0.01, had either no effect or even decreased the
number of transgene expressing cells.
If the sPLA2 homology domain is involved in endosomal release,
addition of endosomolytically active agents such as PEI or adenovirus
should increase the infectivity of the mutant. As the base level, a
transduction efﬁciency of approximately 10% was chosen for both,
76HD/AN and rAAV2-wt, (Fig. 4). First, we assayed the chemical
endosomolytic agent PEI for its ability to aid 76HD/AN transduction.
PEI is a positively charged polymer that, after entering cells via heparan
sulfate proteoglycan (HSPG) (Payne et al., 2007), is passed along the
endolysosomal pathway (Lungwitz et al., 2005) and disrupts endosomal
vesicles by acting as a proton sponge (Yang and May, 2008). Because
both, PEI and AAV2, bind to HSPG (Payne et al., 2007; Summerford and
Samulski, 1998), receptor competition is likely to occur upon co-
application of PEI and AAV2. In an effort to minimize receptor
competition, PEI was added to cells 1 h after they had been transduced
with rAAV2-wt or 76HD/AN. Nevertheless, the transduction efﬁciency of
both, rAAV2-wt and 76HD/AN,was signiﬁcantly reduced in the presence
of PEI (Fig. 5A). In order to explore whether the reduced transduction
efﬁciency was due to impaired vector uptake following addition of PEI,
we determined the number of intracellular particles in HeLa cellsFig. 3. Complementation assay. HeLa cells were incubated with a GOI of 2×105, 2×104 or 2×
conformation, and none (black bars), 2×105 (dotted bars), 2×104 (striped bars) or 2×103 (che
analyzed for GFP expression byﬂow cytometry. Values obtained for untreated cellswere subtracincubated with 76HD/AN for 1 and 3 h in the absence or presence of PEI
(added at 1 h post transduction (p.t.)). Comparison of the values
obtained at 1 h p.t. and at 3 h p.t. in the absence of PEI showed that a
large proportion of vector particles entered the cells later than 1 h p.t.
(Fig. 5B). Therefore, addition of PEI at 1 h p.t. likely interfered with the
cellular uptake of these particles as evidenced by the reduced number of
intracellular particles (Fig. 5B; gray bar vs. black bar). Hence, in contrast
to MVM, PEI was not suitable to study the sPLA2 function of AAV.
Next, we investigated the effect of adenovirus on 76HD/AN's
transduction efﬁciency. Like AAV, adenovirus type 5 (Ad) is
internalized by receptor-mediated endocytosis (Sanlioglu et al.,
2000; Volpers and Kochanek, 2004). Upon endosomal maturation,
Ad inserts an amphipatic α-helix, located at the N-terminus of
structural protein VI, into the endosomal membrane leading to its
dissolution (Wiethoff et al., 2005). In order to rescue 76HD/AN,
potentially trapped in endosomes, Ad needs to be co-localized with
76HD/AN in the same endosome. Hence, we ﬁrst conﬁrmed by imaging
that co-localization is possible (Fig. 6). Next, we co-infected HeLa cells
with 76HD/AN and an increasing concentration of wtAd (up to
500 pfu). For comparison, co-infections of rAAV2-wt and wtAd were
performed. As indicated in Fig. 7A, adenovirus co-infection increased
76HD/AN's transduction efﬁciency by up to 3.4-fold in a103, respectively, of 76HD/AN encoding for GFP in the self-complementary vector genome
cked bars) genomic particles of wild-type AAV2 virions. Cells were harvested 24 h p.i. and
ted. Results are shownas relative numbers ofGFP expressing cells±SEM (n=3). *pb0.05.
Fig. 5. Inﬂuence of PEI on the transduction efﬁciency. A) HeLa cells were incubatedwith a
GOI of 10 of rAAV2-wt (wt) and a GOI of 2×105 of 76HD/AN, respectively, in the absence
(black bars) or presence (gray bars) of 40 μM branched PEI, which was added 1 h p.t. The
percentage of transgene expressing cells was determined 24 h p.t. by ﬂow cytometry.
Background levels obtained for untreated cells were subtracted. Results are shown as
relative numbers of GFP expressing cells±SD (n=3)with values obtained in the absence
of PEI set as 1. B) HeLa cells were incubated with a GOI of 500 of 76HD/AN. Cells were
harvested 1 h p.t. or incubated for a further 2 h in the absence (−PEI) or presence of 40 μM
PEI (+PEI) at 37 °C. Total DNA was isolated and analyzed by qPCR. For normalization
plasminogen activator was used as the reference gene. Results are shown as relative
number of intracellular genomes±SEM (n=3).
Fig. 6. Immunoﬂuorescence staining of HeLa cells co-infected with rAAV2-wt or 76HD/AN an
(105 capsids/cell) and Ad5-Alexa488 (104 particle/cell) for 30 min on ice, then shifted to 37
anti-capsid antibody A20 (and RRX-conjugated secondary antibody; red), nuclear lamina wa
antibody; blue). (A) AAV2-wt capsids detected by A20. (D) 76HD/AN capsids detected by A2
show the merged images of (A)/(B) and (D)/(E), respectively, and the lamina staining. Ana
80 S. Stahnke et al. / Virology 409 (2011) 77–83concentration-dependent manner. Although co-infection of wtAd also
helped to increase the transduction efﬁciency of rAAV2-wt (to 2.3-
fold), the helper effect on 76HD/AN was signiﬁcantly more pro-
nounced (Fig. 7A).
Wild-type Ad not only possess an intrinsic endosomolytic activity
(Volpers and Kochanek, 2004), but also provide helper functions for
AAV2 upon adenoviral gene expression (Cotmore and Tattersall,
2007). The increased transduction efﬁciency of 76HD/AN is thus
probably due to a combination of both helper effects. To investigate
this possibility, we tested the effect of high-capacity (gutless)
adenoviral vectors (rAd), which are devoid of all adenoviral genes
(Volpers and Kochanek, 2004) and therefore lack helper functions
provided by newly produced adenoviral gene products. We co-
incubated HeLa cells with increasing concentrations of rAd (up to
200 pfu) and either 76HD/AN or rAAV2-wt, respectively (Fig. 7B). In
contrast to wtAd, co-infection with rAd had no effect on rAAV2-wt
transduction, suggesting that the increased transduction efﬁciency of
rAAV2-wt observed in the presence of wtAd (Fig. 7A) was due to
helper effects provided by adenoviral gene expression. For 76HD/AN,
however, an increase in transduction efﬁciency was observed after co-
infection with rAd (Fig. 7B), consistent with a function of sPLA2 in
endosomal release of the mutant. Since co-localization of both virions
is required for endosomal escape, signiﬁcant rescue efﬁciencies were
only achieved at higher concentrations of rAd (Fig. 7B).
Further evidence for a function of AAV2's sPLA2 in endosomal
escape was obtained by co-infection of 76HD/AN and Ad2-ts1
(Gastaldelli et al., 2008), an adenoviral endosomal escape mutant
(Fig. 7C). For comparison, HeLa cells were transduced with 76HD/AN
in the presence and absence of rAd, and with rAAV2-wt in the absence
or presence of rAd and Ad2-ts1, respectively. A signiﬁcant increase in
the transduction efﬁciency of 76HD/AN was seen in cells co-infected
with rAd, whereas co-infection with the mutant Ad2-ts1 failed to
complement the sPLA2 defect of 76HD/AN (Fig. 7C). Together, these
results indicate that the sPLA2 activity of AAV2 is involved in
endosomal escape.
Although, like Farr et al. (2005), we made use of an sPLA2 catalytic
center mutant and relied on the same helper effect, namely
adenovirus-mediated endosomal disruption, the complementationd Ad5-Alexa488. HeLa cells were infected with AAV2-wt (105 capsids/cell) or 76HD/AN
°C and incubated for further 30 min. Intact capsids were stained with the monoclonal
s visualized by a polycloncal anti-Lamin B IgG antibody (and Cy5-conjugated secondary
0. (B) and (E) show the Alexa488 signals of the labeled Ad5 capsids (green). (C) and (F)
lyses were performed by confocal laser scanning microscopy.
Fig. 7. Adenoviral helper effect on rAAV2-wt- and 76HD/AN-mediated transductions.
A) HeLa cells were infected with wtAd and 76HD/AN (triangle) or rAAV2-wt
(wt, diamond) for 24 h. B) HeLa cells were infected with rAd and 76HD/AN (triangle)
or rAAV2-wt (wt, diamond) for 24 h. C) HeLa cells were infected with rAAV2-wt (wt) or
76HD/AN in the absence (gray bars) or presence of rAd (pfu of 200; black bars) or Ad2-
ts1 (pfu of 200; hatched bars), respectively, for 24 h. Transduction efﬁciency was
determined by ﬂow cytometry. In A–C) cells were incubated with a GOI of 10 for rAAV2-
wt and a GOI of 2×105 for 76HD/AN, respectively. Background levels obtained for
untreated cells were subtracted. Results are shown as fold increase in transgene
expressing cells±SEM (A, B) or SD (C) (n=3). *pb0.05; **pb0.005; ***pb0.0005;
ns=not signiﬁcant.
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observed in our study. One explanation for this difference could be
the simple fact that H42R was used as a replication-competent virus,
while we made use of a replication-incompetent AAV vector. In the
case of H42R, conceivably, incoming and newly replicated viral
genomes could contribute to the production of capsids, which were
used to trace viral infectivity, while in our study only the incoming
vector genomes could be used as templates. Also, we cannot exclude
the possibility that in A9 cells stably transducedwith the Ad5 receptor
CAR (Volpers and Kochanek, 2004), co-localization of Ad and H42R
might occur more frequently than in the HeLa cells used in our study
(Fig. 6). Furthermore, while Farr et al. carried out immunohistologicalanalyses to determine the rescue efﬁciency, we employed ﬂow
cytometry.
Hence, although a direct comparison of the rescue efﬁciencies in
both studies is difﬁcult, the observation that adenovirus-mediated
endosomal disruption resulted in a signiﬁcant increase in the
transduction efﬁciency of 76HD/AN (Fig. 7) and the infectivity of
H42R (Farr et al., 2005) strongly argues for sPLA2-mediated lipolytic
pore formation (Mudhakir and Harashima, 2009) as an evolutionary
conserved endosomal escape strategy of autonomously replicating
and helper-virus-dependent members of the parvovirus family.
Material and methods
Cell culture
The human cervix epitheloid cell line HeLa (ATCC CCL-2; American
Type Culture Collection, Rockville, USA) and the human embryonic
kidney cell line 293 (HEK293; ATCC CRL-1573; American Type Culture
Collection) were maintained as a monolayer culture at 37 °C and 5%
CO2 in Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented
with GlutaMax™ (Invitrogen, Darmstadt, Germany), 10% fetal calf
serum, 100 U/ml penicillin and 100 mg/ml streptomycin.
Vector production and puriﬁcation
AAV particles were produced in HEK293 cells by the adenovirus-
free AAV production method (Hacker et al., 2005; Xiao et al., 1998).
Brieﬂy, HEK293 cells were seeded at 80% conﬂuency and co-
transfected using the calcium phosphate method with 7.5 μg of pRC
(Girod et al., 1999) or pRC-HD/AN, 7.5 μg of pscAAV/EGFP (Hacker
et al., 2005) and 22.5 μg of pXX6 (Xiao et al., 1998) for the production
of recombinant particles or with 15 μg of plasmid of pUC-AV2 (Girod
et al., 1999) or pUC-AV2-HD/AN (Girod et al., 2002) and 22.5 μg of
pXX6 for production of AAV2 particles encoding for wild-type
genomes without or with the HD/AN mutation, respectively. After
48 h, cells were harvested and pelleted by low-speed centrifugation.
Cells were re-suspended in 150 mM NaCl/50 mM Tris–HCl (pH 8.5),
freeze–thawed three times, and treated with Benzonase (50 U/ml
lysate) for 30 min at 37 °C. To purify viral vector preparations, cell
debris was removed by centrifugation at 3700×g for 20 min at 4 °C,
and the supernatant was loaded onto a discontinuous iodixanol
gradient (Hacker et al., 2005). The 40% phase of the gradient,
containing the vector particles, was harvested. Genomic particle titers
of vector preparations were determined by quantitative (q) PCR
(Theiss et al., 2003) using GFP primers (see below) or cap primers
(3201, GGTACGACGACGATTGCC; 4066, ATGTCCGTCCGTGTGTGG),
respectively. Capsid titers were determined by enzyme-linked
immunosorbent assay (ELISA) using the anti-capsid antibody A20
(Girod et al., 1999). Monoclonal A20 hybridoma supernatant was
kindly provided by Jürgen Kleinschmidt (DKFZ, Heidelberg,
Germany).
Quantiﬁcation of AAV entry efﬁciency
A total of 4×104 HeLa cells were seeded per well in a 12-well plate.
HeLa cells were incubated with 1×104 genomic particles per cell of
rAAV2-wt or 76HD/AN, respectively. Both vectors contain the
enhanced green ﬂuorescent protein (GFP) as reporter gene under
the control of the Cytomegalovirus (CMV) promoter in the self-
complementary vector genome conformation. Cells were incubated
on ice for 30 min, then shifted to 37 °C and incubated at 37 °C and 5%
CO2 for 1 h. Supernatant was removed and cells were washed twice
with 1× PBS. Cells were harvested by trypsin treatment, pelleted,
washed three times in 1× PBS, and total DNA was isolated (DNeasy
Tissue Kit, Qiagen, Hilden, Germany). Relative quantiﬁcation of vector
genomes and reference gene (glyceraldehydes-3-phosphate
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Cycler (LC) rapid thermal cycler system (Roche Diagnostics, Man-
nheim, Germany) and the SYBR Green kit (Roche Diagnostics). The
following primers were chosen for vector genome and reference gene
ampliﬁcation: GFP_rev, 5′-CTCGATGTTGTGGCGGAT-3′ and GFP_fwd,
5 ′ -GCGCCGAGGTGAAGTT -3 ′ , GAPDH_ fwd , 5 ′ -GAGTC-
CACTGGCGTCTTCA-3′ and GAPDH_rev, 5′-TTCAGCTCAGGATGACCTT-
3′. PCR ampliﬁcation was performed as follows: 5 min denaturation at
95 °C, followed by 40 cycles of 15 s at 95 °C, 10 s at 60 °C, and 30 s at
72 °C. The speciﬁcity of target and reference gene ampliﬁcation was
conﬁrmed by melting curve analysis. GFP values were normalized to
GAPDH levels using the RelQuant software (Roche Diagnostics).
Transduction experiments
A total of 4×104 HeLa cells were seeded per well in a 12-well plate.
After 24 h, cells were transduced by vectors as indicated. For
experiments shown in Fig. 3 cells were co-infected with wild-type
AAV2, for experiments in Fig. 7 co-infection was performed with
adenovirus type 5, gutless recombinant adenoviral vectors type 5 or
the adenoviral type 2 ts-1 mutant, respectively. Cells were incubated
at 37 °C and 5% CO2. In case of the rAAV expression kinetic, the
transduction was carried out on ice for 30 min before shifted to 37 °C.
If not stated otherwise, cells were harvested 24 h post transduction by
trypsin treatment, re-suspended in 1× PBS, and analyzed by ﬂow
cytometry using the BD FACS Calibur system (Becton Dickinson,
Heidelberg, Germany). A minimum of 10,000 cells was analyzed per
sample. Data were analyzed usingWinMDI 2.8 ﬂuorescence-activated
cell sorting software.
Imaging studies
A total of 4×104 HeLa cells per well were seeded onto 12-mm
coverslips in 24-well plates. For experiment shown in Fig. 2A, HeLa
cells were incubated with 104 genomic particles of rAAV2-wt or 76HD/
AN for 30 min on ice, then shifted to 37 °C and further incubated for
2 h at 37 °C and 5% CO2. Cells were washed with 1× PBS, ﬁxed for
15 min in 3% paraformaldehyde (PFA)/PBS at room temperature, and
washed with 50 mM NH4Cl in 1× PBS. The remaining PFA was
quenched for 30 min with 50 mM NH4Cl in 1× PBS. For antibody
staining, cells were permeabilized with 0.2% Triton X-100 in 1× PBS
for 10 min, blocked for 10 min with 0.2% gelatine in 1× PBS, and
incubated for 1 h at room temperature with the polyclonal goat anti-
Lamin B IgG antibody (1:50 in 1× PBS; Santa Cruz Biotechnology) and
supernatants of monoclonal A20 mouse hybridoma cells (kindly
provided by Jürgen Kleinschmidt, DKFZ). After washing and blocking,
the cells were incubated for 1 h with the following secondary
antibodies: Cy5-conjugated donkey anti-goat antibody (Dianova,
diluted 1:100 in 1× PBS), Rhodamine Red-X (RRX)-conjugated
donkey anti-mouse (Dianova, diluted 1:100 in 1× PBS). The coverslips
were again washed in 1× PBS, embedded in Vectashield mounting
medium (Alexis), and subjected to confocal laser scanning microsco-
py. For experiments shown in Fig. 6, HeLa cells were incubated with
105 capsids per cell of AAV2-wt (encoding for wild-type genomes) or
76HD/AN (encoding for wild-type genomes with the HD/AN muta-
tion) and Ad5-Alex488 (104 particle/cell, labeled with a 20-fold molar
excess of amine-reactive TFP-Alexa488 (Invitrogen) over capsid
surface amine groups according to Espenlaub et al., 2010) for
30 min on ice, then shifted to 37 °C and further incubated at 37 °C
and 5% CO2 for 30 min. All subsequent steps were conducted as
described above. For nuclear staining, polyclonal goat anti-lamin B IgG
antibody (1:50 in 1× PBS; Santa Cruz Biotechnology) and for
detection of AAV capsids supernatants of monoclonal A20 mouse
hybridoma cells (kindly provided by Jürgen Kleinschmidt, DKFZ) was
used. As secondary antibodies Cy5-conjugated donkey anti-goat
antibody (Dianova, diluted 1:100 in 1× PBS) and Rhodamine Red-X(RRX)-conjugated donkey anti-mouse (Dianova, diluted 1:100 in 1×
PBS) were applied.
Chemically induced endosomolysis
For FACS analysis, a total of 4×104 HeLa cells were seeded per well
in a 12-well plate. After 24 h, HeLa cells were incubated with a GOI of
10 of rAAV2-wt and 2×105 of 76HD/AN, respectively, for 30 min on ice
and followed by 1 h at 37 °C. Branched PEI (average molecular weight
25 kDa (Sigma-Aldrich, Munich, Germany); 1 mg/ml stock solution
neutralized with hydrochloric acid to pH 7.1) was added to the
medium at a ﬁnal concentration of 40 μMand cells were analyzed 23 h
post PEI addition by ﬂow cytometry. For qPCR analysis, a total of
4×104 HeLa cells were seeded per well in a 12-well plate. After 24 h,
HeLa cells were incubated with a GOI of 500 of 76HD/AN for 30 min on
ice followed by 1 h incubation at 37 °C. The “1 h samples” were
harvested by trypsin treatment and total DNA was isolated (DNeasy
Tissue Kit, Qiagen). Furthermore, cells were incubated for further 2 h
at 37 °C in the absence or presence of 40 μM PEI. Subsequently, cells
were harvested and DNA was isolated as described above. Relative
quantiﬁcation of vector genomes and reference gene was performed
by qPCR as described above using GFP (see above) and plasminogen
activator (PLAT) primers (PLAT_fw, ACCTAGACTGGATTCGTG, PLA-
T_rev, AGAGGCTAGTGTGCAT), respectively. The speciﬁcity of target
and reference gene ampliﬁcation was conﬁrmed by melting curve
analysis. Values obtained for the target gene were normalized to PLAT
levels using the RelQuant software (Roche Diagnostics).
Statistical analysis
Statistical analyses were performed using the Student's t-test. A
value of Pb0.05 was considered as statistically signiﬁcant.
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